Tramadol Hydrochloride
Product Images NDC 52605-010

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 52605-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Polygen Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Tramadol-100-count (Tramadol 100 Count)

Tramadol-100-count (Tramadol 100 Count)
This is a medication label for NDC 52605-010-01, with each tablet containing 50mg of Tramadol Hydrochloride, USP. Dosage and prescribing information can be found in the accompanying N traMA_Drog Medication Guide. Store the tablets at 68°-77° F and keep them out of reach of children. This medication is manufactured and distributed by PolyGen Pharmaceuticals Inc.*
FDA Label Image

Tramadol-1000-count (Tramadol 1000 Count)

Tramadol-1000-count (Tramadol 1000 Count)
This is a pharmaceutical product, specifically Tramadol Hydrochloride tablets. The tablets are white, coated, capsule-shaped and contain 50mg of Tramadol Hydrochloride. They are sold in a tight container and should be stored between 20-25 degrees Celsius. Dosage and other information can be found in the package insert. The pharmacist should dispense a medication guide to each patient and keep the product out of reach of children. This product is manufactured and distributed by Pol/Gon Pharmacoutas in Edgewood, NY, USA.*
FDA Label Image

Pharmacokinetics Figure (Tramadol Fig1)

Pharmacokinetics Figure (Tramadol Fig1)
The text seems to be a graph showing the concentration of Tramadol (in mg/mL) at different time intervals (in hours) both in single and multiple doses. The concentration of Tramadol goes down over time as expected. There is no further information available to provide a more detailed description.*
FDA Label Image

Clinical Studies Figure (Tramadol Fig2)

Clinical Studies Figure (Tramadol Fig2)
The text describes a chart or a graph displaying the percentage of individuals who discontinued using a certain protocol (CAPSS-047) due to nausea or vomiting over a period of time in double-blind. The chart shows two different periods of 10 and 16 days respectively, where 10 to 16 individuals out of 200 discontinued the protocol due to nausea or vomiting. There are also markings indicating certain times in days.*
FDA Label Image

Chemical Structure (Tramadol Str)

Chemical Structure (Tramadol Str)
HCI stands for Human-Computer Interaction, which is the study of how people interact with computers and other digital technologies. It involves the design, development and evaluation of user interfaces, as well as understanding human behavior and cognition in relation to technology. HCI is an interdisciplinary field that draws on psychology, computer science, design and engineering, among others, and plays a crucial role in the development of intuitive and user-friendly interfaces for a wide range of applications and devices.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.